NasdaqGM - Nasdaq Real Time Price USD

PROCEPT BioRobotics Corporation (PRCT)

58.07
-0.04
(-0.07%)
At close: May 16 at 4:00:01 PM EDT
57.01
-1.06
(-1.83%)
After hours: May 16 at 7:47:12 PM EDT
Advanced Chart
Loading Chart for PRCT
  • Previous Close 58.11
  • Open 58.50
  • Bid 57.89 x 900
  • Ask 73.71 x 200
  • Day's Range 57.21 - 59.06
  • 52 Week Range 47.04 - 103.81
  • Volume 1,524,112
  • Avg. Volume 1,078,824
  • Market Cap (intraday) 3.213B
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) --
  • EPS (TTM) -1.69
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 76.88

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

www.procept-biorobotics.com

756

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about PROCEPT BioRobotics Corporation

Recent News: PRCT

View More
View More

Performance Overview: PRCT

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PRCT
27.88%
S&P 500 (^GSPC)
1.30%

1-Year Return

PRCT
14.78%
S&P 500 (^GSPC)
12.48%

3-Year Return

PRCT
63.58%
S&P 500 (^GSPC)
48.66%

5-Year Return

PRCT
65.91%
S&P 500 (^GSPC)
108.07%

Compare To: PRCT

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

PRCT
PROCEPT BioRobotics Corporation
58.07
-0.07%
Mkt Cap 3.213B
Industry Medical Devices
STE
STERIS plc
251.59
+1.91%
Mkt Cap 24.719B
Industry Medical Devices
CLPT
ClearPoint Neuro, Inc.
13.18
+2.01%
Mkt Cap 372.533M
Industry Medical Devices
GMED
Globus Medical, Inc.
61.25
+5.93%
Mkt Cap 8.292B
Industry Medical Devices
TMDX
TransMedics Group, Inc.
121.58
-0.19%
Mkt Cap 4.114B
Industry Medical Devices
NPCE
NeuroPace, Inc.
17.49
+2.40%
Mkt Cap 573.646M
Industry Medical Devices
INSP
Inspire Medical Systems, Inc.
152.67
+1.99%
Mkt Cap 4.503B
Industry Medical Devices
IRTC
iRhythm Technologies, Inc.
141.00
-0.03%
Mkt Cap 4.501B
Industry Medical Devices
OM
Outset Medical, Inc.
19.50
-0.26%
Mkt Cap 345.585M
Industry Medical Devices
CBLL
CeriBell, Inc.
17.97
+2.16%
Mkt Cap 649.49M
Industry Medical Devices
LIVN
LivaNova PLC
44.40
+1.32%
Mkt Cap 2.421B
Industry Medical Devices

Statistics: PRCT

View More

Valuation Measures

Annual
As of 5/16/2025

  • Market Cap

    3.21B

  • Enterprise Value

    2.98B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.38

  • Price/Book (mrq)

    8.26

  • Enterprise Value/Revenue

    11.96

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -36.20%

  • Return on Assets (ttm)

    -13.36%

  • Return on Equity (ttm)

    -27.62%

  • Revenue (ttm)

    249.12M

  • Net Income Avi to Common (ttm)

    -90.19M

  • Diluted EPS (ttm)

    -1.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    316.21M

  • Total Debt/Equity (mrq)

    21.02%

  • Levered Free Cash Flow (ttm)

    -58.77M

View More

Research Analysis: PRCT

View More
View More

Company Insights: PRCT

Research Reports: PRCT

View More
View More

People Also Watch

RXST RxSight, Inc.
14.19
+6.61%
 
NUVL Nuvalent, Inc.
73.32
+3.27%
 
JANX Janux Therapeutics, Inc.
24.28
+4.34%
 
TMDX TransMedics Group, Inc.
121.58
-0.19%
 
EWTX Edgewise Therapeutics, Inc.
14.78
+2.28%
 
ACLX Arcellx, Inc.
58.78
+0.56%
 
PCVX Vaxcyte, Inc.
31.85
+3.07%
 
CWAN Clearwater Analytics Holdings, Inc.
23.83
-0.75%
 
CTKB Cytek Biosciences, Inc.
2.6700
-0.37%
 
INTA Intapp, Inc.
58.28
+2.37%
 
TYRA Tyra Biosciences, Inc.
9.99
+1.32%
 
RNA Avidity Biosciences, Inc.
30.35
+4.76%
 
TMCI Treace Medical Concepts, Inc.
6.72
-0.44%
 
CRNX Crinetics Pharmaceuticals, Inc.
31.24
+0.10%
 
VERA Vera Therapeutics, Inc.
21.25
-0.38%
 
CRDO Credo Technology Group Holding Ltd
60.13
+0.92%